Psychiatric Issues in Solid Organ Transplantation

REFERENCES

• Weisbord SD, Kimmel PL. Health-related quality of life in the era of erythropoietin. Hemodial Int 2008;12:6–15.
   PubMedGoogle Scholar
• United Network of Organ Sharing. Designated transplant program criteria. http://www.unos.org/policiesandBylaws2/bylaws/UNOSByLaws/pdfs/bylaw_120.pdf
   Google Scholar
• Dew MA, Roth LH, Thompson ME, Kormos RL, Griffith BP. Medical compliance and its predictors in the first year after heart transplantation. J Heart Lung Transplant 1996;15:631–45.
   PubMed Web of Science ®Google Scholar
• DiMartini A, Twillman R. Organ transplantation in paranoid schizophrenia: two case studies. Psychosomatics 1994;35:159–64.
   PubMedGoogle Scholar
• Levenson JL, Olbrisch MR. Psychosocial evaluation of organ transplant candidates: a comparative survey of the process, criteria, and outcomes in heart, liver and kidney transplantation. Psychosomatics 1993;34:314–23.
   PubMed Web of Science ®Google Scholar
• DiMartini A, Weinrieb R, Fireman M. Liver transplantation in patients with alcohol and other substance use disorders. Psychiatr Clin North Am 2002;25:195–209.
   PubMedGoogle Scholar
• Gedaly R, McHugh PP, Johnston TD, et al. Predictors of relapse to alcohol and illicit drugs after liver transplantation for alcoholic liver disease. Transplantation 2008;86:1090–5.
   PubMed Web of Science ®Google Scholar
• Nickels M, Jain A, Sharma R, et al. Polysubstance abuse in liver transplant patients and its impact on survival outcome. Exp Clin Transplant 2007;5:680–5.
   PubMed Web of Science ®Google Scholar
• Pfitzman R, Schwenze J, Rayes N, et al. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl 2007;13:197–205.
   PubMedGoogle Scholar
• De Gottardi A, Spahr L, Gelez P, et al. A simple score for predicting alcohol relapse after liver transplantation. Arch Intern Med 2008;167:1183–8.
   Google Scholar
• Koch M, Banys P. Liver transplantation and opioid dependence. JAMA 2001;285:1056–8.
   PubMed Web of Science ®Google Scholar
• Botha P, Peaston R, White K, et al. Smoking after cardiac transplantation. Am J Transplant 2008;8:866–71.
   PubMedGoogle Scholar
• Levenson J, Olbrisch ME. Psychosocial screening and selection of candidates for organ transplantation. In: The transplant patient. Trzepacz PT, DiMartini AF, eds. Cambridge: Cambridge University Press, 2000: 21–41.
   Google Scholar
• Organ Procurement and Transplantation Network. Survival by donor type (deceased vs. living). 2009. At http://optn. transplant.hrsa.gov/latestData/step2.asp? (Category = Survival; Organ = All; Survival Type = Patient).
   Google Scholar
• Rodrigue JR, Pavlakis M, Danovitch GM. Evaluating living kidney donors: relationship types, psychosocial criteria, and consent processes at US transplant programs. Am J Transplant 2007;7:2326–32.
   PubMed Web of Science ®Google Scholar
• Gentry SE, Segev DL, Simmerling M, Montgomery RA. Expanding kidney paired donation through participation by compatible pairs. Am J Transplant 2007;7:2361–70.
   PubMed Web of Science ®Google Scholar
• Elbekai RH, Korashy HM, El-Kadi AO. The effect of liver cirrhosis on the regulation and expression of drug metabolizing enzymes. Curr Drug Metab 2004;5:157–67.
   PubMed Web of Science ®Google Scholar
• Gabardi S, Abramson S. Drug dosing in chronic kidney disease. Med Clin North Am 2005;89:649–87.
   PubMed Web of Science ®Google Scholar
• De Geest S, Borgermans L, Gemoets H, et al. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation 1995;59:340–7.
   PubMedGoogle Scholar
• Dew MA, Kormos RL, Roth LH, Murali S, DiMartini A, Griffith BP. Early post-transplant medical compliance and mental health predict physical mortality and mortality one to three years after heart transplantation. J Heart Lung Transplant 1999;18:549–62.
   PubMed Web of Science ®Google Scholar
• Bunzel B, Laederach-Hofmann K. Solid organ transplantation: are there predictors for post transplant noncompliance? A literature overview. Transplantation 2000;70:711–6.
   PubMed Web of Science ®Google Scholar
• Shapiro PA, Williams DL, Foray AT, Gelman IS, Wukich N, Sciacca R. Psychosocial evaluation and prediction of compliance problems and mortality after heart transplant. Transplantation 1995;60:1462–6.
   PubMed Web of Science ®Google Scholar
• Cukor D, Newville H, Jindal R. Depression and immunosuppressive medication adherence in kidney transplant patients. Gen Hosp Psychiatry 2008;30:316–7.
   Google Scholar
• Trzepacz PT, DiMartini A, Tringali R. Psychopharmacologic issues in organ transplantation. Part I: Pharmacokinetics in organ failure and psychiatric aspects of immunosuppressants and anti-infectious agents. Psychosomatics 1993;34:199–207.
   PubMed Web of Science ®Google Scholar
• Fireman M, DiMartini AF, Armstrong SC, Cozza KL. Med-psych drug-drug interactions update. Immunosuppressants. Psychosomatics 2004;45:354–60.
   PubMed Web of Science ®Google Scholar
• Drug-induced convulsions; report from the Boston Collaborative Drug Surveillance Program. Lancet 1972;30:677–9.
   Google Scholar
• Bartynski WS, Tan HP, Boardman JF, Shapiro R, Marsh JW. Posterior reversible encephalopathy syndrome after solid organ transplantation. Am J Neuroradiol 2008;29:924–30.
   PubMed Web of Science ®Google Scholar
• Nghiem DD. Role of pharmacologic enhancement of P-450 in cyclosporine overdose. Transplantation 2002;74:1355–6.
   PubMedGoogle Scholar
• Mrvos R, Hodgman M, Krenzelok EP. Tacrolimus (FK 596) overdose: a report of five cases. J Toxicol Clin Toxicol 1997;35:395–9.
   PubMed Web of Science ®Google Scholar
• Wright DH, Lake KD, Bruhn PS, Emery RW Jr. Nefazodone and cyclosporine drug-drug interaction. J Heart Lung Transplant 1999;18:913–5.
   PubMed Web of Science ®Google Scholar
• Vella JP, Sayegh MH. Interactions between cyclosporine and newer antidepressant medications. Am J Kidney Dis 1998;31:320–3.
   PubMed Web of Science ®Google Scholar
• Cervelli MJ, Russ GR. Itraconazole-tacrolimus drug interaction. Ther Drug Monit 2003;25:483–4.
   PubMedGoogle Scholar
• Van Gelder T. Drug interactions with tacrolimus. Drug Saf 2002;25:707–12.
   PubMed Web of Science ®Google Scholar
• Levy GA. Long-term immunosuppression and drug interactions. Liver Transpl 2001;7: S53–9.
   Google Scholar
• Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clin Pharmacokinet 2007;46:13–58.
   PubMed Web of Science ®Google Scholar
• Bartels OM, Decker O, Harms J, Hauss J, Fangmann J. Changes in quality of life after renal transplant. Transplant Proc 2005;37:1618–21.
   PubMedGoogle Scholar
• Dew MA, Roth LH, Schulberg HC, et al. Prevalence and predictors of depression and anxiety-related disorders during the first year after heart transplant. Gen Hosp Psychiatry 1996;18(6 suppl):48S–61S.
   Google Scholar
• Dew MA, Kormos RL, DiMartini AF, et al. Prevalence and risk of depression and anxiety-related disorders during the first three years after heart transplantation. Psychosomatics 2001;42:300–13.
   PubMed Web of Science ®Google Scholar
• Dobbels F, Skeans MA, Snyder JJ, Tuomari AV, Maclean JR, Kasiske BL. Depressive disorders in renal transplantation: an analysis of Medicare claims. Am J Kidney Dis 2008;51:819–28.
   PubMed Web of Science ®Google Scholar
• Ojo, AO, Hanson, JA, Wolfe, RA, Leichtman AB, Agodoa LY, Port FK. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000;57:307–13.
   PubMed Web of Science ®Google Scholar
• Limbos MM, Joyce DP, Chan CKN, Kesten S. Psychological functioning and quality of life in lung transplant candidates and recipients. Chest 2000;118:408–16.
   PubMed Web of Science ®Google Scholar
• Stukas AA, Dew MA, Switzer GE, DiMartini A, Kormos RL, Griffith BP. PTSD in heart transplant recipients and their primary family caregivers. Psychosomatics 1999;40:212–21.
   PubMed Web of Science ®Google Scholar
• Shitrit D, Lev N, Bar-Gil-Shitrit, Kramer MR. Progressive multifocal leukoencephalopathy in transplant recipients. Transpl Int 2005;17:658–65.
   PubMed Web of Science ®Google Scholar
• Crone CC, Gabriel GM. Treatment of anxiety and depression in transplant patients. Clin Pharmacokinet 2004;43:361–94.
   PubMed Web of Science ®Google Scholar
• Carlat DJ. Drug metabolism in psychiatry: a clinical guide. Newburyport, MA: Clearview, 2006.
   Google Scholar
• Opatrny L, Delaney JA, Suissa S. Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look. Br J Clin Pharmacol 2008;66:76–81.
   PubMed Web of Science ®Google Scholar
• Thase ME. Effects of venlafaxine on blood pressure; a meta-analysis of original data from 3744 depressed patients. J Clin Psychiatry 1998;59:502–8.
   PubMed Web of Science ®Google Scholar
• Masand P, Tesar G. Use of stimulants in the medically ill. Psychiatr Clin North Am 1996;19:515–47.
   PubMed Web of Science ®Google Scholar
• DeGeest S, Schafer-Keller P, Denhaerynck K, et al. Supporting medication adherence in renal transplantation (SMART): a pilot RCT to improve adherence to immunosuppressive regimens. Clin Transplant 2006; 20:359–68.
   PubMedGoogle Scholar
• Abbey S, Farrow S. Group therapy and organ transplantation. Int J Group Psychother 1998;48:163–85.
   PubMed Web of Science ®Google Scholar
• Baines LS, Joseph JT, Jindal RM. Prospective randomized study of individual and group psychotherapy versus controls in recipients of renal transplants. Kidney Int 2004;65:1937–42.
   PubMed Web of Science ®Google Scholar
• Gross CR, Kreitzer MJ, Reilly-Spong M, Winbush NY, Schomaker EK, Thomas W. Mindfulness meditation training to reduce symptom distress in transplant patients: rationale, design, and experience with a recycled waitlist. Clin Trials 2009;6:76–89.
   PubMed Web of Science ®Google Scholar
• Showalter PE, Young SA, Bilello JF, Schafer TR, Shaver TR. Electroconvulsive therapy for depression in a liver transplant patient. Psychosomatics 1993;34:537.
   PubMedGoogle Scholar
• Jayaram G, Casimir A. Major depression and the use of electroconvulsive therapy (ECT) in lung transplant recipients. Psychosomatics 2005;46:244–9.
   PubMedGoogle Scholar